Thrombosis Clinical Trials in Beijing, Beijing Municipality

10 recruitingBeijing, Beijing Municipality, China

Showing 110 of 10 trials

Recruiting
Phase 3

Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

Stroke, IschemicDrug EffectStroke, Acute+1 more
Xuanwu Hospital, Beijing850 enrolled1 locationNCT06658197
Recruiting

Clinical Application of Wearable Ultrasound Sensors

DVT - Deep Vein ThrombosisPOCUS
Chinese PLA General Hospital300 enrolled1 locationNCT07009873
Recruiting
Phase 4

Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis

Cerebral Venous Thrombosis
Xuanwu Hospital, Beijing72 enrolled1 locationNCT07352358
Recruiting
Not Applicable

CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

Deep Venous ThrombosisVenous ThromboembolismPulmonary Embolism+2 more
China-Japan Friendship Hospital5,800 enrolled1 locationNCT04211181
Recruiting

Cerebral Microembolization Associated With PFO Closure

Atrial Septal DefectPatent Foramen Ovale (PFO)Thrombosis Cardiac
China National Center for Cardiovascular Diseases800 enrolled1 locationNCT06347276
Recruiting

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Anticoagulant TherapyCerebral Venous ThrombosisAnticoagulant Drugs+6 more
Xuanwu Hospital, Beijing1,486 enrolled1 locationNCT06947707
Recruiting

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

ThrombophiliaThrombosisArterial Thromboembolism+13 more
Peking University People's Hospital3,000 enrolled5 locationsNCT06727669
Recruiting
Not Applicable

Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)

Cerebral Venous Sinus Thrombosis
Beijing Tiantan Hospital224 enrolled1 locationNCT06583889
Recruiting

Thrombus Imaging and Treatment Analytics in Neurology

ThrombosisThrombus, Brain
Chinese PLA General Hospital100 enrolled1 locationNCT05663281
Recruiting
Phase 2

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

Hepatocellular CarcinomaRadiotherapyPembrolizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT06389422